ICH E9 guideline 'Statistical principles for clinical trials': a case study - Response

被引:4
|
作者
Brown, DJ [1 ]
机构
[1] Med Control Agcy, London SW8 5NQ, England
关键词
D O I
10.1002/sim.1329
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [1] ICH E9 guideline 'Statistical principles for clinical trials': a case study
    Phillips, A
    Haudiquet, V
    STATISTICS IN MEDICINE, 2003, 22 (01) : 1 - 11
  • [2] Statistical principles for clinical trials (ICH E9) an introductory note on an international guideline
    Lewis, JA
    STATISTICS IN MEDICINE, 1999, 18 (15) : 1903 - 1904
  • [3] Impact of the ICH E9 Guideline Statistical Principles for Clinical Trials on the Conduct of Clinical Trials in Japan
    Chihiro Hirotsu
    Ludwig A. Hothorn
    Drug information journal : DIJ / Drug Information Association, 2003, 37 : 381 - 395
  • [4] The impact of the international guideline entitled statistical principles for clinical trials (ICH E9)
    Lewis, J
    Louv, W
    Rockhold, F
    Sato, T
    STATISTICS IN MEDICINE, 2001, 20 (17-18) : 2549 - 2560
  • [5] Impact of the ICH E9 guideline statistical principles for clinical trials on the conduct of clinical trials in Japan
    Hirotsu, C
    Hothorn, LA
    DRUG INFORMATION JOURNAL, 2003, 37 (04): : 381 - 395
  • [6] Clinical and Statistical Perspectives on the ICH E9(R1) Estimand Framework Implementation
    Ionan, Alexei C.
    Paterniti, Miya
    Mehrotra, Devan, V
    Scott, John
    Ratitch, Bohdana
    Collins, Sylva
    Gomatam, Shanti
    Nie, Lei
    Rufibach, Kaspar
    Bretz, Frank
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2023, 15 (03): : 554 - 559
  • [7] Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice
    Bohdana Ratitch
    James Bell
    Craig Mallinckrodt
    Jonathan W. Bartlett
    Niti Goel
    Geert Molenberghs
    Michael O’Kelly
    Pritibha Singh
    Ilya Lipkovich
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 324 - 341
  • [8] Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice
    Ratitch, Bohdana
    Bell, James
    Mallinckrodt, Craig
    Bartlett, Jonathan W.
    Goel, Niti
    Molenberghs, Geert
    O'Kelly, Michael
    Singh, Pritibha
    Lipkovich, Ilya
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 324 - 341
  • [9] Assessing the impact of ICH E9
    Brown, David
    Day, Simon
    Hemmings, Rob
    Wright, David
    PHARMACEUTICAL STATISTICS, 2008, 7 (02) : 77 - 87
  • [10] 10 years of ICH E9
    Lewis, John
    PHARMACEUTICAL STATISTICS, 2008, 7 (01) : 1 - 3